Background: Down syndrome is one of the commonest causes of intellectual disability. As life expectancy improves with early and more intensive surgical and medical treatments, people with the disorder are more likely to exhibit classic morbidity and mortality patterns and be diagnosed with diseases such as cancer. Methods: A profile of cancer cases among people with Down syndrome has been compiled, based on the analysis of a linked data set that included information from the Disability Services Commission of Western Australian and the State Cancer Registry. Results and conclusions: Although the total age- and sex-standardized incidence ratios (SIRs) for people with Down syndrome were similar to that for the general population, SIRs for leuk...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
This study investigated mortality and causes of death between 1988 and 1999 in 14 781 persons (6702 ...
Review on Down syndrome, with data on clinics, susceptibility to neoplasms, and the genes involve
International audienceCancer in Down syndrome (DS) is characterized by a well known and marked exces...
OBJECTIVE: To determine the risk of cancers and selected immune related diseases in people with Down...
A cohort study of 1425 persons with Down's syndrome (DS), and of their parents (447 mothers, 435 fat...
Objective: During the last 50 years there have been significant improvements in life expectancy amon...
Abstract: Cancer in Down syndrome (DS) is characterized by a well known and marked excess of leukemi...
Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased to...
Purpose: Given the current life expectancy and number of individuals living with Down syndrome (DS),...
Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased to...
ObjectiveTo assess leukemia risks among children with Down syndrome in a large, contemporary cohort....
Down syndrome (DS) is a congenital chromosomal abnormality caused by the presence of all or part of ...
<p>UTAZIA: Utah, Arizona, Iowa.</p>*<p>Rates are per 100,000 Person Years.</p>†<p><i>P</i> < 0.05;</...
Breast cancer is the most frequent malignant neoplasm observed among women. For the subgroup of wome...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
This study investigated mortality and causes of death between 1988 and 1999 in 14 781 persons (6702 ...
Review on Down syndrome, with data on clinics, susceptibility to neoplasms, and the genes involve
International audienceCancer in Down syndrome (DS) is characterized by a well known and marked exces...
OBJECTIVE: To determine the risk of cancers and selected immune related diseases in people with Down...
A cohort study of 1425 persons with Down's syndrome (DS), and of their parents (447 mothers, 435 fat...
Objective: During the last 50 years there have been significant improvements in life expectancy amon...
Abstract: Cancer in Down syndrome (DS) is characterized by a well known and marked excess of leukemi...
Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased to...
Purpose: Given the current life expectancy and number of individuals living with Down syndrome (DS),...
Persons with Down syndrome (DS) uniquely have an increased frequency of leukemias but a decreased to...
ObjectiveTo assess leukemia risks among children with Down syndrome in a large, contemporary cohort....
Down syndrome (DS) is a congenital chromosomal abnormality caused by the presence of all or part of ...
<p>UTAZIA: Utah, Arizona, Iowa.</p>*<p>Rates are per 100,000 Person Years.</p>†<p><i>P</i> < 0.05;</...
Breast cancer is the most frequent malignant neoplasm observed among women. For the subgroup of wome...
Background: Late health consequences of treatment for childhood leukemia are well documented. Althou...
This study investigated mortality and causes of death between 1988 and 1999 in 14 781 persons (6702 ...
Review on Down syndrome, with data on clinics, susceptibility to neoplasms, and the genes involve